Clinical Overview
Retinoids are a class of chemical compounds derived from Vitamin A that bind to Retinoic Acid Receptors (RAR) and Retinoid X Receptors (RXR) in the skin. They are the gold standard in dermatology for treating photoaging, acne vulgaris, and hyperpigmentation.
Mechanism of Action
Retinoids act on a cellular level to alter gene expression. They accelerate epidermal cellular turnover, inhibit tyrosinase activity (reducing melanin synthesis), prevent the degradation of collagen by inhibiting matrix metalloproteinases (MMPs), and stimulate dermal fibroblasts to produce new Type I and Type III collagen.
The Conversion Pathway
All over-the-counter retinoids must be enzymatically converted by the skin into active Retinoic Acid.
Formulation Challenges
Retinoids are highly unstable when exposed to light (UV) and air (oxygen). Formulators must utilize specialized delivery systems such as liposomal encapsulation, solid lipid nanoparticles, or strictly anhydrous matrices (like squalane or silicones) to prevent degradation during shelf life. Furthermore, they require opaque, airless pump packaging.